KIF2C and pancreatic adenocarcinoma: The prognostic evaluation of KIF2C in TCGA cancer cohorts revealed that the expression level of KIF2C was significantly correlated with the overall survival rate of the patients with ACC, KIRC, KIRP, LGG, LIHC, LUAD, MESO, and PAAD (Figure 11C).